Supplementary Figures S1-S4 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial

<p>Supplementary Figure 1: Study flow-chart. Supplementary Figure 2: Kaplan-Meier curves of event-free survival according to tertile-split tumor mutational burden. Supplementary Figure 3. Kaplan-Meier curves of recurrence-free survival according to the molecular subtype. Supplementary Figure 4...

Полное описание

Сохранить в:

Библиографические подробности
Главный автор:	Giuseppe Basile (15051269) (author)
Другие авторы:	Marco Bandini (15051272) (author), Ewan A. Gibb (15051275) (author), Jeffrey S. Ross (15030824) (author), Daniele Raggi (15051278) (author), Laura Marandino (15051281) (author), Tiago Costa de Padua (15051284) (author), Emanuele Crupi (15051287) (author), Renzo Colombo (15051290) (author), Maurizio Colecchia (15051293) (author), Roberta Lucianò (15051296) (author), Luigi Nocera (15051299) (author), Marco Moschini (15051302) (author), Alberto Briganti (15051305) (author), Francesco Montorsi (15051308) (author), Andrea Necchi (15044772) (author)
Опубликовано:	2025
Предметы:	Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Phase II clinical trials Genitourinary Cancers Bladder cancer Immunotherapy
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Supplementary Figures S1-S4 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial

Схожие документы